TD Cowen reiterates Braze stock rating citing growth levers

TD Cowen reiterated a Buy rating on Braze with a $30 price target, implying upside from the current $21.87 share price and roughly 2.8x EV/calendar 2027 sales. The firm cited 27% trailing revenue growth, 66% gross margin, improving net revenue retention, and AI monetization as key drivers, while noting the stock trades below peers on valuation. Recent quarterly results were mixed but still showed 30% revenue growth, and multiple analysts remain constructive despite some margin misses.

Analysis

The market is still treating BRZE like a high-quality but crowded SaaS re-rating, yet the more interesting setup is operational leverage inflecting faster than consensus models imply. Once a platform gets past the first leg of growth, small improvements in retention and expansion can add disproportionate value because incremental revenue drops through at a much higher rate; that makes next year’s margin progression the real catalyst, not the headline growth rate. The multiple gap to peers is likely less about fundamentals than about investor skepticism that AI monetization can offset historical go-to-market friction.

The second-order winner is likely the broader customer engagement/software stack, because if Braze can prove that AI features drive paid expansion instead of just being a packaging story, it resets the pricing power debate for adjacent vendors. That would pressure slower-growth incumbents that rely on seat-based or feature-bundle monetization, while benefiting names that can show consumption-like expansion without visibly hurting retention. The bigger competitive risk is not a direct product leapfrog, but a normalization of deal cycles if enterprise buyers decide Braze is becoming a strategic platform rather than a point solution.

The main near-term risk is that the current optimism already assumes clean execution into the next several quarters. Any slippage in gross margin, operating margin, or AI attach rates would be punished because the stock is being bought on a re-acceleration thesis, not on absolute valuation alone. The contrarian read is that the discount may persist longer than bulls expect if investors keep demanding proof that the new products are monetizing at scale rather than just improving engagement metrics.

Key Decisions for Investors

• Go long BRZE on a 3-6 month horizon into the next two reporting periods; use a starter position now and add only if management confirms AI product monetization traction. Risk/reward is attractive if the market begins to price a credible path to 10%+ operating margins, but execution misses will likely compress the multiple quickly.
• Buy BRZE Jan-2026 $25/$35 call spreads to express upside to re-rating without paying full premium for a straight equity long. This captures a valuation gap close over the next 6-12 months while capping downside to the premium paid.
• Pair trade: long BRZE / short a slower-moving mid-cap SaaS name with similar customer profile but weaker NRR or margin trajectory. The trade benefits if investors reward operating leverage and AI monetization more than just headline growth.
• If you already own BRZE, hedge ahead of earnings with short-dated puts or a collars structure; the stock is vulnerable to a sharp de-rating if margin or gross margin prints miss by even modestly versus elevated expectations.
• Watch for a better entry after any post-earnings drawdown of 8-12%; that would likely create a cleaner risk/reward if the selloff is driven by temporary margin noise rather than deterioration in customer expansion.